s6y Co-Diagnostics, Inc. 10-Q

Co-Diagnostics, Inc. 10-Q, filed Nov 12, 2021: IDEA: XBRL DOCUMENT

Earnings Per Share
9 Months Ended
Sep. 30, 2021
Earnings Per Share [Abstract]  
Earnings Per Share

Note 5 – Earnings Per Share

 

The following table reconciles the numerator and the denominator used to calculate basic and diluted earnings per share for three and nine months ended September 30, 2021 and 2020:

 

   Three Months Ended September 30,   Nine Months Ended September 30, 
   2021   2020   2021   2020 
Numerator                    
Net income (loss), as reported  $11,475,966   $15,731,532   $29,160,154   $29,671,348 
                     
Denominator                    
Weighted average shares, basic   28,941,357    28,084,267    28,800,450    26,172,439 
Dilutive effect of stock options, warrants and RSUs   1,011,333    1,513,525    1,071,965    1,449,092 
Shares used to compute diluted earnings per share   29,952,690    29,597,792    29,872,415    27,621,531 
                     
Basic earnings per share  $0.40   $0.56   $1.01   $1.13 
Diluted earnings per share  $0.38   $0.53   $0.98   $1.07 

 

For the three and nine months ended September 30, 2021, potentially dilutive securities of 50,000 and 147,436 were excluded from the calculation because their effect would have been anti-dilutive. For the three and nine months ended September 30, 2020, potentially dilutive securities of 50,000 were excluded from the calculation because their effect would have been anti-dilutive.